These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 33027365

  • 1. Cardiovascular Risk and Statin Eligibility in Primary Prevention: A Comparison between the Brazilian and the AHA/ACC Guidelines.
    Cesena FHY, Valente VA, Santos RD, Bittencourt MS.
    Arq Bras Cardiol; 2020 Sep; 115(3):440-449. PubMed ID: 33027365
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.
    Pagidipati NJ, Navar AM, Mulder H, Sniderman AD, Peterson ED, Pencina MJ.
    JAMA; 2017 Apr 18; 317(15):1563-1567. PubMed ID: 28418481
    [Abstract] [Full Text] [Related]

  • 3. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT, Kaplan RC, Swett K, Burke G, Daviglus M, Jung M, Talavera GA, Chirinos DA, Reina SA, Davis S, Rodriguez CJ.
    J Am Heart Assoc; 2017 May 11; 6(5):. PubMed ID: 28495699
    [Abstract] [Full Text] [Related]

  • 4. Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey.
    Gupta K, Kakar TS, Jain V, Gupta M, Al Rifai M, Slipczuk L, Nambi V, Bittner V, Blumenthal RS, Stone NJ, Lavie CJ, Virani SS.
    Prog Cardiovasc Dis; 2022 May 11; 75():78-82. PubMed ID: 36038004
    [Abstract] [Full Text] [Related]

  • 5. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
    Pavlovic J, Greenland P, Deckers JW, Brugts JJ, Kavousi M, Dhana K, Ikram MA, Hofman A, Stricker BH, Franco OH, Leening MJ.
    JAMA Cardiol; 2016 Sep 01; 1(6):708-13. PubMed ID: 27439175
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA, Möhlenkamp S, Lehmann N, Kälsch H, Dykun I, Pundt N, Moebus S, Jöckel KH, Erbel R, Heinz Nixdorf Recall Study Investigators.
    JACC Cardiovasc Imaging; 2017 Feb 01; 10(2):143-153. PubMed ID: 27665163
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular Risk Stratification and Statin Eligibility Based on the Brazilian vs. North American Guidelines on Blood Cholesterol Management.
    Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Santos RD, Bittencourt MS.
    Arq Bras Cardiol; 2017 Jun 01; 108(6):508-517. PubMed ID: 28699974
    [Abstract] [Full Text] [Related]

  • 9. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E, Rittner SS, Carroll JE, Crawford PM, Dant L, Laws R, Leo MC, Puro J, Persell SD.
    J Am Heart Assoc; 2017 Jul 03; 6(7):. PubMed ID: 28673901
    [Abstract] [Full Text] [Related]

  • 10. Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction.
    Mortensen MB, Falk E.
    BMJ Open; 2014 Oct 17; 4(10):e005991. PubMed ID: 25326211
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T, Zhou S, Anzalone D, Kern DM, Tunceli O, Cziraky MJ, Willey VJ.
    J Am Heart Assoc; 2017 May 04; 6(5):. PubMed ID: 28473405
    [Abstract] [Full Text] [Related]

  • 13. Increased statin eligibility based on ACC/AHA versus NCEP guidelines for high cholesterol management in Chile.
    Echeverría G, Dussaillant C, Villarroel L, Rigotti A.
    J Clin Lipidol; 2016 May 04; 10(1):192-8.e1. PubMed ID: 26892136
    [Abstract] [Full Text] [Related]

  • 14. Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.
    Pavlović J, Greenland P, Deckers JW, Kavousi M, Hofman A, Ikram MA, Franco OH, Leening MJ.
    Eur J Prev Cardiol; 2018 Mar 04; 25(4):420-431. PubMed ID: 29171772
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
    Bellows BK, Olsen CJ, Voelker J, Wander C.
    J Manag Care Spec Pharm; 2016 Aug 04; 22(8):892-900. PubMed ID: 27459651
    [Abstract] [Full Text] [Related]

  • 18. Use of Statins for Primary Prevention: Selection of Risk Threshold and Implications Across Race and Gender.
    Goyal A, Cooper HA, Aronow WS, Nagpal P, Yandrapalli S, Nabors CC, Frishman WH.
    Am J Med; 2018 Oct 04; 131(10):1234-1237. PubMed ID: 29928863
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.